Literature DB >> 28316446

Should we reconsider platelet content criteria for single donor platelets in West Bengal, India?

Rizwan Javed1, Sabita Basu1.   

Abstract

Entities:  

Year:  2017        PMID: 28316446      PMCID: PMC5345287          DOI: 10.4103/0973-6247.200771

Source DB:  PubMed          Journal:  Asian J Transfus Sci        ISSN: 0973-6247


× No keyword cloud information.
Sir, As a tertiary oncology center in Eastern India, we cater to transfusion needs of a large number of patients from the Eastern region and neighboring countries. As part of quality control (QC), NABH and AABB have specified a minimum platelet content of 3 × 1011 in single donor platelet (SDP) concentrates. A lower mean platelet count is reported in West Bengal native donors and could potentially result in lower platelet yield in SDP donations.[1] We examined platelet yield in SDP products from volunteer West Bengal native donors. We retrospectively analyzed SDP collections at our transfusion medicine unit over 7 months from January 1, 2015, to July 31, 2015. SDP collections were performed using the MCS+ 9000 system from Haemonetics, USA. The collection efficiency of the equipment ranged from 56% to 60%. Product platelet counts were assessed using the Coulter Ac Tdiff2 instrument (Beckman Coulter). Donors free of transfusion-transmitted infections, hemoglobin between 12.5 and 18 g/dl, and having a minimum platelet count of 1.5 lakhs/cumm were taken up for donations. We identified two categories of SDP donors; Category A: West Bengal native donors (West Bengal residents with Bengali as mother tongue) and Category B: non-native donors. A total of 311 donors were screened, and 252 procedures were performed. QC data were available in 182 SDP donations (72% of donations). SDP collections from Category A donors had significantly lower platelet content as compared with Category B donors (Chi-square statistical test, P < 0.05). Based on existing QC specifications, 70.5% of SDP collections from Category A donors were deemed unsatisfactory [Table 1]. Relatively, lower mean platelet counts are reported in West Bengal natives. Constitutional macrothrombocytopenia has also been reported in this region[23] [Table 2].
Table 1

Distribution of donors in our study

Table 2

Comparison of different studies

Distribution of donors in our study Comparison of different studies Roy et al. reported that SDPs from donors with giant platelets led to better platelet recovery in patients and suggested that donors with giant platelets should be eligible for SDP donations.[4] The current QC criteria for SDP products are too stringent for donors from Eastern India and exclude a significant proportion of otherwise suitable volunteer SDP donors. We call for a review of QC criteria for SDP donations from native donors and suggest that this can be linked to the analysis of platelet recovery in transfused patients.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  4 in total

1.  Asymptomatic constitutional macrothrombocytopenia among West Bengal blood donors.

Authors:  Harris Vezhappilly Kunjali Naina; Sukesh C Nair; Dolly Daniel; Biju George; Mammen Chandy
Journal:  Am J Med       Date:  2002-06-15       Impact factor: 4.965

2.  Harris syndrome - a geographic perspective.

Authors:  H V K Naina; S C Nair; S Harris; G Woodfield; M I Rees
Journal:  J Thromb Haemost       Date:  2005-11       Impact factor: 5.824

Review 3.  Congenital and acquired thrombocytopenia.

Authors:  Douglas B Cines; James B Bussel; Robert B McMillan; James L Zehnder
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2004

4.  Giant Platelets in Platelet Donors - A Blessing in Disguise?

Authors:  Asitava Deb Roy; Nabajyoti Choudhury; Deepanjan Ray
Journal:  J Clin Diagn Res       Date:  2015-06-01
  4 in total
  1 in total

1.  Analysis of Donor Safety in High Yield Plateletpheresis Procedures: An Experience from Tertiary Care Hospital in South India.

Authors:  Vijay Kumawat; Manu Goyal; Palniappan Marimuthu
Journal:  Indian J Hematol Blood Transfus       Date:  2020-02-27       Impact factor: 0.900

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.